ID: h-var-d636c381a4
Hypothesis

Lysosomal Clearance Capacity Determines Therapeutic Window—Autophagy Enhancement Required Before Critical Accumulation

The therapeutic hypothesis centers on the kinetic constraints governing autophagy-lysosomal degradation of pathological protein aggregates, specifically targeting the mTORC1/ULK1 autophagy initiation pathway and lysosomal processing capa.
🧬 ULK1 (autophagy initiation kinase)🩺 protein-folding🎯 Composite 38%proposed
protein folding
EvidencePending (0%)📖 8 cit🗣 1 debates 8 support 2 oppose
✓ All Quality Gates Passed

🧪 Overview

The therapeutic hypothesis centers on the kinetic constraints governing autophagy-lysosomal degradation of pathological protein aggregates, specifically targeting the mTORC1/ULK1 autophagy initiation pathway and lysosomal processing capacity. At the molecular level, this mechanism involves mTORC1-mediated phosphorylation of ULK1 at Ser757, which inhibits autophagy initiation under nutrient-rich conditions. Upon cellular stress or aggregate accumulation, mTORC1 inhibition allows ULK1 autophosphorylation at Ser317 and subsequent activation of the autophagy cascade through Beclin-1/VPS34 complex recruitment and LC3 lipidation. The kinetic model predicts that aggregate clearance follows Michaelis-Menten kinetics, where Vmax represents the maximum lysosomal degradation capacity determined by lysosome number, cathepsin activity levels (particularly cathepsin B and L), and autophagosome-lysosome fusion efficiency mediated by SNARE proteins and Rab7. The Km reflects the aggregate concentration required for half-maximal clearance, influenced by selective autophagy receptor binding (p62/SQSTM1, NBR1) to LC3-decorated autophagosomes.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Seed amplification threshold RT-QuIC diagnostic<br/>Hypothesis Target"]
    B["Pathway Dysregulation<br/>Cited Mechanism"]
    C["Cellular Response<br/>Stress or Clearance Change"]
    D["Neural Circuit Effect<br/>Synapse/Glia Vulnerability"]
    E["Neurodegeneration<br/>Disease-Relevant Outcome"]
    A --> B
    B --> C
    C --> D
    D --> E
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style B fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix8 supports2 contradicts
Supports
Hsp70 chaperone activity follows saturable Michaelis-Menten kinetics
Supports
RT-QuIC seed titrations demonstrate exponential amplification above detection threshold
Supports
Substoichiometric inhibition of disaggregation above critical aggregate loads observed in Hsp104 studies
Supports
Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1.
Cancer Res2024PMID:38888469medium
Supports
Energy deficiency impairs resistance training gains in lean mass but not strength: A meta-analysis and meta-regression.
Scand J Med Sci Sports2022PMID:34623696medium
Supports
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma.
Nat Commun2022PMID:36302754medium
Supports
Oncogenic Addiction of Fibrolamellar Hepatocellular Carcinoma to the Fusion Kinase DNAJB1-PRKACA.
Clin Cancer Res2023PMID:36302174medium
Supports
EGFR phosphorylates DNAJB1 to suppress α-synuclein aggregation in Parkinson's disease.
NPJ Parkinsons Dis2025PMID:40483356medium
Contradicts
Chaperone systems are regulated by stress responses; Vmax may not be fixed
Contradicts
Species extrapolation from yeast Hsp104 to mammalian Hsp70/Hsp40 may be invalid
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — ULK1

🧬 PDB 4WNO Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for ULK1 (autophagy initiation kinase) from GTEx v10.

Cerebellum108 Cerebellar Hemisphere89.4 Nucleus accumbens basal ganglia84.7 Cortex54.5 Caudate basal ganglia50.2 Frontal Cortex BA944.0 Putamen basal ganglia36.9 Anterior cingulate cortex BA2432.4 Hippocampus25.7 Amygdala24.0 Hypothalamus23.9 Substantia nigra14.3 Spinal cord cervical c-110.9median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for ULK1 (autophagy initiation kinase) →

No DepMap CRISPR Chronos data found for ULK1 (autophagy initiation kinase).

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
0

💾 Resource Usage

LLM Tokens
28,822
$0.0865
Total Cost
$0.0865
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.